The UK government has announced a £100 million public-private investment to establish 20 Commercial Research Delivery Centres (CRDCs) across the nation. These centres, equipped with state-of-the-art technology, aim to expand access to clinical trials for cutting-edge treatments. Covering regions across England, Scotland, Wales, and Northern Ireland, the initiative ensures inclusivity and accessibility for all communities.

Focusing on major health challenges such as cancer, obesity, and infectious diseases, the CRDCs are part of a £400 million joint investment scheme. This initiative will boost the UK’s life sciences sector and drive economic growth.

The plan includes simplifying clinical trial processes through new regulations to speed up approvals. By shifting trials into community settings, it increases participation and aligns with the government’s 10-Year Health Plan, which prioritises prevention and healthier living.

This transformative investment underscores the UK’s leadership in global health innovation and its commitment to building a healthier future for all.